-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on BioNTech, Lowers Price Target to $138

Benzinga·06/16/2025 11:42:54
Listen to the news
HC Wainwright & Co. analyst Robert Burns maintains BioNTech (NASDAQ:BNTX) with a Buy and lowers the price target from $145 to $138.